Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | XYLO |
---|---|---|
09:46 ET | 100 | 3.84 |
09:48 ET | 1100 | 3.76 |
09:50 ET | 9239 | 3.9 |
09:51 ET | 7605 | 4 |
09:53 ET | 3511 | 3.998 |
09:55 ET | 7897 | 3.88 |
09:57 ET | 2201 | 3.8201 |
10:00 ET | 1100 | 3.82 |
10:02 ET | 2383 | 3.82 |
10:04 ET | 3386 | 4.0762 |
10:06 ET | 4967 | 4.1504 |
10:08 ET | 5857 | 4.35 |
10:09 ET | 6135 | 4.2204 |
10:11 ET | 1568 | 4.4413 |
10:13 ET | 877 | 4.45 |
10:15 ET | 1343 | 4.3799 |
10:18 ET | 1250 | 4.2893 |
10:20 ET | 2464 | 4.3 |
10:22 ET | 238 | 4.23 |
10:24 ET | 483 | 4.22 |
10:26 ET | 5522 | 4.1235 |
10:27 ET | 500 | 4.1235 |
10:29 ET | 1500 | 4.1582 |
10:31 ET | 1000 | 4.11 |
10:33 ET | 500 | 4.04 |
10:38 ET | 1200 | 3.9001 |
10:40 ET | 1300 | 4.0698 |
10:42 ET | 1078 | 3.9801 |
11:02 ET | 500 | 4.09 |
11:03 ET | 3400 | 4.05 |
11:09 ET | 1000 | 4.025 |
11:16 ET | 2000 | 4.0001 |
11:18 ET | 4202 | 3.98 |
11:32 ET | 2000 | 3.9383 |
11:48 ET | 300 | 3.96 |
11:50 ET | 830 | 3.9 |
11:54 ET | 100 | 3.88 |
11:59 ET | 100 | 3.89 |
12:12 ET | 1300 | 3.85 |
12:21 ET | 113 | 3.8206 |
12:24 ET | 1000 | 3.82 |
12:30 ET | 910 | 3.82 |
12:35 ET | 768 | 3.79 |
12:46 ET | 100 | 3.79 |
12:50 ET | 500 | 3.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Xylo Technologies Ltd | 2.7M | -0.1x | --- |
ViewRay Inc | 180.0 | 0.0x | --- |
Vaso Corp | 22.5M | 68.3x | --- |
Venus Concept Inc | 2.5M | 0.0x | --- |
Akoya Biosciences Inc | 109.0M | -1.9x | --- |
Neuronetics Inc | 29.2M | -0.8x | --- |
Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7M |
---|---|
Revenue (TTM) | $57.6M |
Shares Outstanding | 18.3K |
Dividend Yield | 23.29% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.46 |
EPS | $-62.20 |
Book Value | $89.85 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.74% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.